We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 3,279 results
  1. Symptomatic and neurotrophic effects of GABAA receptor positive allosteric modulation in a mouse model of chronic stress

    Chronic stress is a risk factor for Major Depressive Disorder (MDD), and in rodents, it recapitulates human behavioral, cellular and molecular...

    Ashley Bernardo, Philip Lee, ... Thomas D. Prevot in Neuropsychopharmacology
    Article 14 June 2022
  2. GABAA receptor and anti-titin antibody encephalitis in a patient with thymoma

    Autoimmune encephalitis (AE) associated to antibodies against GABA A R is a rare form of encephalitis. On the other hand, thymoma has been linked to...

    Maria Tappatà, Maria Pia Giannoccaro, ... Andrea Zini in Neurological Sciences
    Article 16 June 2022
  3. Extrasynaptic δGABAA receptors mediate resistance to migraine-like phenotype in rats

    Background

    GABA, a key inhibitory neurotransmitter, has synaptic and extrasynaptic receptors on the postsynaptic neuron. Background GABA, which spills...

    Berkay Alpay, Bariscan Cimen, ... Yildirim Sara in The Journal of Headache and Pain
    Article Open access 10 May 2024
  4. Enhanced hippocampal LTP but normal NMDA receptor and AMPA receptor function in a rat model of CDKL5 deficiency disorder

    Background

    Mutations in the X-linked gene cyclin-dependent kinase-like 5 ( CDKL5 ) cause a severe neurological disorder characterised by early-onset...

    Laura Simões de Oliveira, Heather E. O’Leary, ... Peter C. Kind in Molecular Autism
    Article Open access 14 June 2024
  5. Neurophysiological evidence that frontoparietal connectivity and GABA-A receptor changes underpin the antidepressant response to ketamine

    Revealing the acute cortical pharmacodynamics of an antidepressant dose of ketamine in humans with depression is key to determining the specific...

    Rachael L. Sumner, Rebecca L. McMillan, ... Alexander D. Shaw in Translational Psychiatry
    Article Open access 24 February 2024
  6. Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future

    The predominant inhibitory neurotransmitter in the brain, γ-aminobutyric acid (GABA), acts at ionotropic GABA A receptors to counterbalance excitation...

    Scott M. Thompson in Neuropsychopharmacology
    Article 14 September 2023
  7. Altered excitatory and inhibitory ionotropic receptor subunit expression in the cortical visuospatial working memory network in schizophrenia

    Dysfunction of the cortical dorsal visual stream and visuospatial working memory (vsWM) network in individuals with schizophrenia (SZ) likely...

    Kirsten E. Schoonover, Samuel J. Dienel, ... David A. Lewis in Neuropsychopharmacology
    Article 28 March 2024
  8. 5-HT2A receptor dysregulation in a schizophrenia relevant mouse model of NMDA receptor hypofunction

    Blockade of N -methyl-D-aspartate receptors (NMDAR) is known to augment cortical serotonin 2A receptors (5-HT2ARs), which is implicated in psychosis....

    Kazuhito Nakao, Mahendra Singh, ... Kazu Nakazawa in Translational Psychiatry
    Article Open access 22 April 2022
  9. Progressive encephalomyelitis with rigidity and myoclonus (PERM) associated with anti-glycine receptor antibodies and urothelial carcinoma: a case report

    Background

    Progressive encephalomyelitis with rigidity and myoclonus (PERM) is a rare neurological condition with paraneoplastic etiology in about 20%...

    Amanuel Hassen Ali, Anna Benterud, ... Aija Zuleron Myro in Journal of Medical Case Reports
    Article Open access 03 August 2023
  10. Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation

    Anorexia nervosa is a disorder associated with serious adverse health outcomes, for which there is currently considerable treatment ineffectiveness....

    Jules S. Mitchell, Daniel F. Hermens, ... Jim Lagopoulos in CNS Drugs
    Article Open access 22 January 2023
  11. Dynorphin / kappa-opioid receptor regulation of excitation-inhibition balance toggles afferent control of prefrontal cortical circuits in a pathway-specific manner

    The medial prefrontal cortex (mPFC) controls behavior via connections with limbic excitatory afferents that engage various inhibitory motifs to shape...

    Hector E. Yarur, Sanne M. Casello, ... Hugo A. Tejeda in Molecular Psychiatry
    Article Open access 29 August 2023
  12. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia

    Hippocampal hyperactivity driven by GABAergic interneuron deficits and NMDA receptor hypofunction is associated with the hyperdopaminergic state...

    Amanda Kiemes, Felipe V. Gomes, ... Gemma Modinos in Neuropsychopharmacology
    Article Open access 06 November 2021
  13. Alteration of NMDA receptor trafficking as a cellular hallmark of psychosis

    A dysfunction of the glutamatergic transmission, especially of the NMDA receptor (NMDAR), constitutes one of the main biological substrate of...

    Agnès Espana, Henrik Seth, ... Laurent Groc in Translational Psychiatry
    Article Open access 30 August 2021
  14. The 5-HT1F receptor as the target of ditans in migraine — from bench to bedside

    Migraine is a leading cause of disability in more than one billion people worldwide, yet it remains universally underappreciated, even by individuals...

    Dimos D. Mitsikostas, Christian Waeber, ... Michael A. Moskowitz in Nature Reviews Neurology
    Article 12 July 2023
  15. Modulation of transient receptor potential (TRP) channels by plant derived substances used in over-the-counter cough and cold remedies

    Background

    Upper respiratory tract infections (URTIs) impact all age groups and have a significant economic and social burden on society, worldwide....

    Rebecca J. Stinson, Alyn H. Morice, Laura R. Sadofsky in Respiratory Research
    Article Open access 08 February 2023
  16. Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database

    Background

    Few studies have examined the prescribing patterns of orexin receptor antagonists (ORAs) in the real-world clinical setting in Japan.

    ...
    Shoki Okuda, Zaina P. Qureshi, ... Shigeru Tokita in Drugs - Real World Outcomes
    Article Open access 03 March 2023
  17. Medial prefrontal cortex Notch1 signalling mediates methamphetamine-induced psychosis via Hes1-dependent suppression of GABAB1 receptor expression

    Methamphetamine (METH), a widely abused stimulant drug, induces psychosis in approximately half of abusers; this effect is becoming a major concern...

    Tong Ni, Li Zhu, ... Teng Chen in Molecular Psychiatry
    Article Open access 22 June 2022
  18. Characterization of DREADD receptor expression and function in rhesus macaques trained to discriminate ethanol

    Circuit manipulation has been a staple technique in neuroscience to identify how the brain functions to control complex behaviors. Chemogenetics,...

    Daicia C. Allen, Vanessa A. Jimenez, ... Verginia C. Cuzon Carlson in Neuropsychopharmacology
    Article 15 October 2021
  19. The GABAA receptor modulator zolpidem augments hippocampal-prefrontal coupling during non-REM sleep

    Benzodiazepines and ‘Z-drugs’ (including zolpidem and zopiclone) are GABA A receptor (GABA A R) positive modulators commonly prescribed as hypnotics to...

    Flavie Kersanté, Ross J. Purple, Matthew W. Jones in Neuropsychopharmacology
    Article Open access 18 June 2022
  20. Astrocytes modulate extracellular neurotransmitter levels and excitatory neurotransmission in dorsolateral striatum via dopamine D2 receptor signaling

    Astrocytes provide structural and metabolic support of neuronal tissue, but may also be involved in sha** synaptic output. To further define the...

    Louise Adermark, Oona Lagström, ... Mia Ericson in Neuropsychopharmacology
    Article 22 November 2021
Did you find what you were looking for? Share feedback.